Dual-energy CT for the musculoskeletal system

PI Mallinson, TM Coupal, PD McLaughlin, S Nicolaou… - Radiology, 2016 - pubs.rsna.org
The principal advantages of dual-energy computed tomography (CT) over conventional CT
in the musculoskeletal setting relate to the additional information provided regarding tissue …

Recommendations for the management of autoinflammatory diseases

NM Ter Haar, M Oswald, J Jeyaratnam… - Annals of the …, 2015 - ard.bmj.com
Autoinflammatory diseases are characterised by fever and systemic inflammation, with
potentially serious complications. Owing to the rarity of these diseases, evidence-based …

European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis

W Zhang, M Doherty, T Bardin, V Barskova… - Annals of the …, 2011 - ard.bmj.com
Objectives To agree terminology and to develop recommendations for the diagnosis of
calcium pyrophosphate deposition (CPPD). Methods The European League Against …

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

MA Becker, HR Schumacher, LR Espinoza… - Arthritis research & …, 2010 - Springer
Introduction The purpose of this study was to compare urate-lowering (UL) efficacy and
safety of daily febuxostat and allopurinol in subjects with gout and serum urate (sUA)≥ 8.0 …

Safety and tolerability of available urate-lowering drugs: a critical review

L Strilchuk, F Fogacci, AF Cicero - Expert Opinion on Drug Safety, 2019 - Taylor & Francis
Introduction: Urate-lowering therapy (ULT) is the cornerstone of gout management, which is
a widespread chronic illness characterized by hyperuricemia, arthropathy, tophus …

Gout. Epidemiology of gout

E Roddy, M Doherty - Arthritis research & therapy, 2010 - Springer
Gout is the most prevalent form of inflammatory arthropathy. Several studies suggest that its
prevalence and incidence have risen in recent decades. Numerous risk factors for the …

High versus low dosing of oral colchicine for early acute gout flare: twenty‐four–hour outcome of the first multicenter, randomized, double‐blind, placebo‐controlled …

RA Terkeltaub, DE Furst, K Bennett… - Arthritis & …, 2010 - Wiley Online Library
Objective Despite widespread use of colchicine, the evidence basis for oral colchicine
therapy and dosing in acute gout remains limited. The aim of this trial was to compare low …

Остеоартрит: эпидемиология, классификация, факторы риска и прогрессирования, клиника, диагностика, лечение

ЛИ Алексеева, ЕА Таскина… - Современная …, 2019 - cyberleninka.ru
В статье впервые подробно представлена распространенность остеоартрита (ОА),
рассмотрены предикторы развития и прогрессирования заболевания. Описаны …

Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28‐week, phase III, randomized, double‐blind …

HR Schumacher Jr, MA Becker… - Arthritis Care & …, 2008 - Wiley Online Library
Objective To compare the urate‐lowering efficacy and safety of febuxostat, allopurinol, and
placebo in a large group of subjects with hyperuricemia and gout, including persons with …

Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad …

F Sivera, M Andrés, L Carmona, ASR Kydd… - Annals of the …, 2014 - ard.bmj.com
We aimed to develop evidence-based multinational recommendations for the diagnosis and
management of gout. Using a formal voting process, a panel of 78 international …